Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
42.95
0.26 (0.61%)
At close: Aug 18, 2025, 3:59 PM
42.99
0.09%
After-hours: Aug 18, 2025, 04:10 PM EDT
Supernus Pharmaceuticals Revenue
Supernus Pharmaceuticals reported an annual revenue of $661.82M, reflecting a 8.94% growth. For the quarter ending June 30, 2025, Supernus Pharmaceuticals generated $165.45M in revenue.
Revenue (ttm)
661.82M
Revenue Growth
8.94%
Price / Sales Ratio
3.01
Revenue / Employee
981.92K
Employees
674
Market Cap
2.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 661.82M | +8.94% |
| Dec 31, 2023 | 607.52M | -8.95% |
| Dec 31, 2022 | 667.24M | +15.09% |
| Dec 31, 2021 | 579.77M | +11.41% |
| Dec 31, 2020 | 520.4M | +32.50% |
| Dec 31, 2019 | 392.75M | -3.95% |
| Dec 31, 2018 | 408.9M | +35.29% |
| Dec 31, 2017 | 302.24M | +40.57% |
| Dec 31, 2016 | 215M | +48.87% |
| Dec 31, 2015 | 144.43M | +18.34% |
| Dec 31, 2014 | 122.05M | +915.43% |
| Dec 31, 2013 | 12.02M | +712.09% |
| Dec 31, 2012 | 1.48M | +84.31% |
| Dec 31, 2011 | 803K | +657.55% |
| Dec 31, 2010 | 106K | -99.72% |
| Dec 31, 2009 | 37.92M | +326.65% |
| Dec 31, 2008 | 8.89M | +109.97% |
| Dec 31, 2007 | 4.23M | n/a |